{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-244642","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2021-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.845473+00:00","generated_at":"2026-06-29T13:49:47.105352+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Tarsus Pharmaceuticals appoints Rosemary A. Crane to Board; creates Science and Technology Committee","bullets":["Crane appointed to Board effective Aug 11, 2021; will chair Audit and new Science and Technology Committees.","Jason Tester resigned from Board and Audit Committee on Aug 10, 2021; no disagreement with Company.","Wendy Yarno appointed Chair of Compensation Committee; Andrew Goldberg moved to Science and Technology Committee.","Crane receives initial option for 20,000 shares under non-employee director compensation policy.","Crane brings 30+ years pharma experience, including former CEO of MELA Sciences and Epocrates, senior roles at J&J and Bristol Myers Squibb."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-244642","json":"https://secwatch.observer/filing/0001193125-21-244642.json","markdown":"https://secwatch.observer/filing/0001193125-21-244642.md","text":"https://secwatch.observer/filing/0001193125-21-244642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/0001193125-21-244642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/d166164d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T13:49:47.105352+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f9d323eb2","claim":"Rosemary A. Crane was appointed as Chair of the Science and Technology Committee at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"The Board appointed Ms. Crane to serve as Chair of the Science and Technology Committee","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/0001193125-21-244642-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Science and Technology Committee"}],"fact_type":"executive_change"},{"claim_id":"76f68077a2","claim":"Rosemary A. Crane was appointed as Director at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"appointed Rosemary A. Crane to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/0001193125-21-244642-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"847317a969","claim":"Rosemary A. Crane was appointed as Chair of the Audit Committee at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"the Board appointed Ms. Crane to serve as Chair of the Audit Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/0001193125-21-244642-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Audit Committee"}],"fact_type":"executive_change"},{"claim_id":"ac6a394a6c","claim":"Jason Tester resigned as Director at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"Jason Tester, a member of the Company's Board and Chair of the Audit Committee of the Board, resigned from the Board and the Audit Committee of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000119312521244642/0001193125-21-244642-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}